Ketogenic diet and metabolic syndrome: progress and perspective
10.3760/cma.j.cn311282-20200120-00037
- VernacularTitle:生酮饮食与代谢综合征:进展与展望
- Author:
Peng ZHOU
1
;
Mengxiao ZHANG
;
Xiao WEI
;
Guofang CHEN
;
Chao LIU
Author Information
1. 南京中医药大学附属中西医结合医院内分泌科,江苏省中医药研究院,国家中医药管理局瘿病证治重点研究室 210028
- From:
Chinese Journal of Endocrinology and Metabolism
2020;36(7):626-630
- CountryChina
- Language:Chinese
-
Abstract:
Metabolic syndrome(MS)is a kind of metabolic disorder, including abdominal obesity, hyperglycemia, dyslipidemia, hypertension, etc. It reflects susceptibility to diabetes, cardiovascular disease, and other pathological conditions. In recent years, ketogenic diet(KD), as one of the natural therapies, has been proved to be effective in reducing weight, lowering blood glucose, regulating lipid metabolism, and improving insulin resistance. Therefore, its application in metabolic diseases has attracted more attention. There is growing evidence demonstrating directly or indirectly that KD may be an effective treatment for MS. How to safely and effectively implement KD and explore the biochemical mechanism of KD in the treatment of MS will be the focus of clinical research in the future.